About
iPSC Therapies, Stem Cell Services
Areas of Focus
Categories
Contract ResearchStem Cell & Cellular TherapyContract ManufacturingChina
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
326
By Phase
PHASE1: 2PHASE1/PHASE2: 4EARLY_PHASE1: 1PHASE2: 1
By Status
RECRUITING: 4COMPLETED: 2NOT_YET_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06949137Lead Sponsor
Intravenous Infusion of hMSC100 (hUC-MSC) in Postmenopausal Women With Osteoporosis at High Risk of Fracture
PHASE1Recruiting
18 participants
Started: May 31, 2025 · Completed: Dec 31, 2027
NCT06866600Lead Sponsor
IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure
PHASE1/PHASE2Not yet recruiting
40 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2027
NCT06340048Lead Sponsor
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
PHASE1/PHASE2Recruiting
36 participants
Started: Sep 5, 2023 · Completed: Mar 5, 2025
NCT05566600Lead Sponsor
Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure
EARLY_PHASE1Recruiting
32 participants
Started: Oct 9, 2022 · Completed: Jul 31, 2025
NCT05223894Lead Sponsor
Treating Heart Failure With hiPSC-CMs
PHASE1/PHASE2Recruiting
20 participants
Started: Jun 30, 2022 · Completed: Dec 30, 2025
Locations (1)
Headquarters
Nanjing, China
Map
Loading map...